Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. (NYSE: LDOS) is a leading science and technology company that provides services and solutions in defense, intelligence, civil, and health markets. Headquartered in Reston, Virginia, Leidos leverages the expertise of its 47,000 employees to tackle some of the world's most pressing challenges. The company is divided into several segments, each catering to specific industries:
- National Security and Digital: Focuses on cyber, logistics, security operations, and digital transformation for defense and intelligence customers.
- Health & Civil: Delivers public health solutions, care coordination, and environmental sciences services.
- Commercial & International: Covers security enterprise solutions, commercial energy offerings, and international business.
- Defense Systems: Develops advanced space, aerial, surface, and subsurface defense systems.
Leidos reported revenues of approximately $15.4 billion for the fiscal year ending December 29, 2023. The company’s recent projects include:
- Development of C2IMERA: An advanced command and control tool for the U.S. Air Force.
- MHS GENESIS Deployment: A federal electronic health record system implemented across all Department of Defense garrison facilities.
- Mayhem Hypersonic System: Advancing air-breathing hypersonic technologies through a collaborative national team effort.
Financially, Leidos had a strong 2023 with revenues up by 7%, achieving a record net income margin of 7.1% in the first quarter of 2024. The company remains committed to innovation, operational efficiency, and addressing emerging threats in national security and health.
Leidos has been awarded a prime contract by the CDC to provide bioinformatics and scientific computing support services, valued at over $13 million over five years. This contract enhances CDC's capacity in handling large datasets and high-performance computing for health-related research. The work will be primarily based in Atlanta, Georgia.
Liz Porter, Leidos Health Group president, emphasized the importance of this collaboration in investigating infectious pathogens and advancing public health.
Leidos Holdings has extended its offers for the exchange of various notes totaling $2.25 billion, including 2.950% Notes due 2023 and others, to expire on June 21, 2021. This extension is due to the announcement that June 18 will be a federal holiday. As of June 17, 2021, the company reported significant tendering amounts: 59.7% for the 2023 Notes and over 85% for the 2025 Notes. Other notes tendered include 70.1% for the 2030 Notes and 81.1% for the 2031 Notes. Citibank is the exchange agent for the offers.
Leidos (NYSE: LDOS) has secured a prime contract from the U.S. Army for commercial health services to military reserve forces, valued at $999 million if all options are exercised. This contract spans a one-year base period, with four additional one-year options. Leidos will collaborate with the Defense Health Agency to meet health requirements for service members before, during, and after deployment. Liz Porter, the Health Group president, emphasized the commitment to serving military reservists, while CEO Larry Schaefer stressed the dedication to innovation and customer service in healthcare.
Leidos (NYSE: LDOS) announced its advancement into the final phase of the USSOCOM's Armed Overwatch aircraft prototype program alongside Paramount USA and Vertex. The team has been awarded $19.3 million for prototype demonstrations, focusing on the Bronco II aircraft, which boasts mission flexibility through its Interchangeable Multi-Mission System Bay. Leidos' team aims to showcase the Bronco II's capabilities for ISR, SCAR, and CAS missions. The program is critical for future military operational requirements, showcasing Leidos' ongoing commitment to innovative defense solutions.
Leidos (NYSE: LDOS) announced its advancement to Phase III of the U.S. Special Operations Command's Armed Overwatch aircraft prototype program with its Bronco II aircraft. Partnering with Paramount Group USA and Vertex Aerospace, the Leidos team will demonstrate the aircraft's capabilities in a fly-off. Bronco II is designed for rapid deployment and modularity, allowing for diverse mission configurations. This contract signifies Leidos' commitment to providing advanced military solutions and supporting national defense.
Leidos (NYSE: LDOS), a leader in information technology and engineering, will participate in the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021, at 4:40 p.m. ET. Chris Cage, Corporate Controller and incoming CFO, will engage in a fireside chat during the event. Interested investors can access the live audio webcast on the Leidos Investor Relations website, with a replay available for 90 days post-event. Leidos reported revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021, emphasizing its role in tackling complex challenges across various sectors.
Leidos (NYSE: LDOS) has secured a prime contract worth up to $110 million from the FBI to provide fitness for duty medical exam services. Awarded by the FBI's Human Resources Division, the contract includes a base period of 12 months with four potential 12-month extensions. QTC Medical Services, a subsidiary of Leidos, will offer various occupational health services, building on its existing relationship with the FBI since 2012. This contract expands QTC's role in supporting FBI personnel with comprehensive medical examinations and related services.
Leidos (NYSE: LDOS), a leader in technology and science solutions, will participate in the Bernstein 37th Annual Strategic Decisions Conference on June 2, 2021, at 1:30 p.m. ET. CEO Roger Krone will engage in a Q&A session during the event. The conference will be accessible via a live audio webcast on the Leidos Investor Relations website. Following the event, a replay will be available for one year. Leidos, headquartered in Reston, VA, reported annual revenues of approximately $12.30 billion in the fiscal year ended January 1, 2021.
Leidos Holdings, Inc. (NYSE: LDOS) has successfully completed the acquisition of Gibbs & Cox, Inc. for approximately $380 million in cash. The acquisition allows Gibbs & Cox to operate as a wholly-owned subsidiary under Leidos' maritime systems division, enhancing Leidos' capability to provide engineering solutions to the US Navy and foreign navies. The move is expected to strengthen Leidos' position in the growing maritime undersea, autonomous, and cybersecurity sectors, leveraging Gibbs & Cox's expertise in naval architecture and design.
Leidos Holdings, Inc. (NYSE: LDOS) has successfully acquired Gibbs & Cox, Inc. for approximately $380 million in cash. This acquisition enhances Leidos' maritime capabilities, allowing it to offer broader engineering solutions to the US Navy and international navies. Gibbs & Cox will operate as a wholly owned subsidiary and is known as the largest independent ship design firm in the U.S., specializing in naval architecture and marine engineering. The merger signifies Leidos' commitment to innovation and growth in the maritime sector.
FAQ
What is the current stock price of Leidos Holdings (LDOS)?
What is the market cap of Leidos Holdings (LDOS)?
What does Leidos Holdings, Inc. do?
Where is Leidos Holdings, Inc. headquartered?
How many employees does Leidos have?
What are the main business segments of Leidos?
What were Leidos' revenues for the fiscal year 2023?
What is C2IMERA?
What is MHS GENESIS?
What recent project has Leidos completed for the Air Force Research Lab?
What are the recent financial highlights for Leidos?
How does Leidos contribute to national security?
